content

Janssen to Acquire Investigational Bermekimab from XBiotech

Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, announced that it has entered a definitive agreement to acquire all rights to...

Novartis and Forendo enter into tissue hormone focused licensing collaboration

Finland-based Forendo Pharma has announced it has signed a licensing and collaboration agreement with Novartis. The research collaboration will focus on discovering and developing HSD17B...

Recipharm invests in its US inhalation development service

Recipharm, the contract development and manufacturing organisation (CDMO), has invested USD 450,000 into its Research Triangle Park (RTP), North Carolina, US facility to install...

MedPharm moves into $4M expansion of its North Carolina facility

MedPharm, the leader in topical and transdermal drug delivery, has moved into its newly expanded facility in Durham, North Carolina. The $4M expansion has tripled...

Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced an expanded antibody...

PCI Pharma Services Announces Major Investment to Expand Development and Manufacturing Capabilities at Tredegar, UK Site

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced it has begun an expansion of its Tredegar facility in...

Sanofi Lines Up for Potential Approval of Cold Agglutinin Disease Treatment

Following positive results from a pivotal Phase III trial assessing the safety and efficacy of sutimlimab in people with primary cold agglutinin disease (CAD),...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read